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Caspase-8 downregulation is observed in the epidermis of wounded skin,
whereas permanent epidermal caspase-8 deletion causes chronic skin inﬂam-
mation, suggesting that caspase-8 is a critical regulator of skin homeostasis and,
possibly, the wound response. In this issue, Lee et al. document how epidermal
caspase-8 deletion, or cutaneous wounding, results in increased NF-κB activation
to drive keratinocyte caspase-1 expression and subsequent secretion of the pro-
inﬂammatory cytokines, IL-1β and IL-1α. Consequently, loss of NF-κB activity,
caspase-1, or the IL-1 receptor delays wound healing. Previous studies have
documented how chronic skin inﬂammation in caspase-8-deﬁcient mice is
rescued by RIPK3 co-deletion. Therefore, targeting caspase-1, IL-1, or RIPK3
itself may beneﬁt treatment of chronic inﬂammatory skin diseases, or where an
inappropriate inﬂammatory response proves detrimental to wound healing, such
as in type 2 diabetes.
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Inﬂammasome activity in the skin
The skin provides an essential barrier
against the outside world, including
microbial organisms, environmental
irritants, and physical trauma. As such,
it rapidly detects and responds to
danger signals and, when compro-
mised, the wound response triggers
inﬂammation followed by cellular pro-
liferation, tissue formation, and, even-
tually, tissue remodeling.
The inﬂammatory response following
wounding, and in many chronic inﬂam-
matory diseases, is often a result of
innate-immune pattern recognition
receptor (PRR) activity that incorporates
the Toll-like receptor (TLR) and NOD-
like receptor (NLR) families. These PRRs
survey the extracellular and intra-
cellular environment for danger, and
when activated induce the production
of inﬂammatory mediators, such as
cytokines, or in some circumstances
trigger programmed cell death. This
may include the lytic cell death path-
ways, caspase-1-dependent pyroptosis, or
RIPK3/MLKL-mediated necroptosis. Of
note, PRRs react not only to speciﬁc
pathogen molecules (pathogen-asso-
ciated molecular patterns (PAMPs)) and
to environmental irritants, but also to
host-derived danger molecules (damage-
associated molecular patterns (DAMPs))
that are released from necrotic cells and
tissues following trauma.
A subset of NLRs (e.g., NLRP1,
NLRP3, and NLRC4), Aim2-like recep-
tors, and the tripartite motif family
member Pyrin detect speciﬁc DAMPs
and PAMPs to form cytosolic inﬂamma-
some protein complexes. The inﬂam-
masome adaptor ASC couples pyrin
domain–containing inﬂammasomes,
such as NLRP3 and AIM2, to caspase-1.
Inﬂammasome-mediated caspase-1
dimerization and activation results in
the processing and activation of IL-1β
and IL-18 that are subsequently secreted
along with IL-1α in a caspase-1-
dependent manner. Both IL-1β and
IL-1α act as potent proinﬂammatory
cytokines to trigger pathogen and sterile
inﬂammatory responses through bind-
ing to the IL-1 receptor (IL-1R). IL-1α is
also often classiﬁed as an alarmin or
DAMP and, in a manner similar to that
of IL-33, it can be released passively
from necrotic cells. Although IL-1α is
expressed constitutively and, unlike IL-
-1β, does not require cleavage for
activation, IL-1β and NLRP3 expression
often requires transcriptional induction
through TLR or tumor necrosis factor
(TNF) superfamily receptor signaling,
known as inﬂammasome priming.
Importantly, however, inﬂammasome
activation only occurs upon detection
of a second cellular insult by an
inﬂammasome sensor protein, such
as NLRP3.
Notably, several inﬂammasome
sensors (e.g., NLRP1, NLRP3, AIM2),
the adaptor ASC, inﬂammatory caspases
(e.g., caspase-1, caspase-4, caspase-5),
IL-1β and IL-1α are expressed in kera-
tinocytes (Watanabe et al., 2007;
Dombrowski et al., 2011; Kopfnagel
et al., 2011; Shi et al., 2014), the predo-
minant cell type in the outer layer of
the skin––the epidermis. Keratinocytes
respond to a range of irritants (e.g., UVB
irradiation, trinitro-chlorobenzene,
DNA) by activating NLRP3 or the
DNA sensing AIM2 inﬂammasome to
induce IL-1 secretion. In this regard,
excess inﬂammasome/IL-1 activity in
either keratinocytes or macrophages
has been implicated in several inﬂam-
matory skin conditions such as
psoriasis, atopic dermatitis, contact
hypersensitivity, acne, UVB-induced
skin inﬂammation, as well as impaired
wound healing in type 2 diabetes
(Feldmeyer et al., 2007; Watanabe
et al., 2007; Dombrowski et al., 2011;
Dinarello et al., 2012; Mirza et al.,
2014). Similarly, excess IL-1 activation
caused by genetic mutations (e.g.,
NLRP3 activating (Brydges et al., 2009;
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Meng et al., 2009), sharpin inactivating
(Liang et al.,2011; Rickard et al., 2014))
has been shown to contribute to
inﬂammatory skin diseases in mice and
humans. Deletion of the endogenous
IL-1R antagonist exacerbates IL-1 signal-
ing and delays wound healing (Ishida
et al., 2006), whereas preventing IL-1
signaling by deletion of the IL-1R itself,
or therapeutic blockade of IL-1, curtails
wound-induced inﬂammatory cytokine
production and the ﬁbrotic response
(Thomay et al., 2009). Despite these
advances and the clear importance of
IL-1 to skin homeostasis, the mechan-
isms leading to inﬂammasome activity
and IL-1 production in the wounded skin
remain unclear.
Decreased caspase-8 expression as part
of the wound response
Caspase-8 is the initiator caspase
required for apoptosis following death
receptor activation by the TNF super-
family ligands TNF, Fas ligand, and
TRAIL (tumor necrosis factor–related
apoptosis-inducing ligand). However,
work in the past few years has uncovered
a critical non-apoptotic role for
caspase-8 in repressing necroptotic cell
death mediated by RIPK3 and MLKL
(Khan et al., 2014). For example, the
embryonic lethality of caspase-8-deﬁcient
mice is prevented by RIPK3 co-deletion
(Kaiser et al., 2011; Oberst et al., 2011).
Hence, in many cell types, the loss or
inhibition of caspase-8 results in RIPK3
activation and necroptotic cell death.
More recently, RIPK3 activity in innate-
immune cells has also been shown to
regulate the transcription and production
of inﬂammatory cytokines, such as TNF,
or activate the NLRP3 inﬂammasome in a
cell-intrinsic manner (Vince et al., 2012;
Kang et al., 2013; Moriwaki et al.,
2014; Wong et al., 2014; Lawlor et al.,
2015).
Jamora and colleagues (Lee et al.,
2009) documented previously that skin
wounding results in reduced caspase-8
expression in the thickened epidermis
proximal to a site of wounding and
that its expression is restored following
wound closure. Similar to these
ﬁndings, in this issue (Lee et al., 2015),
work from the Jamora laboratory
demonstrates that an in vitro scratch
“wound” ablates caspase-8 protein
expression in keratinocytes at the
scratch edge and that this correlates
directly with increased NF-κB activation
and caspase-1 levels. Consistent with
these observations being physiologi-
cally important, reduced caspase-8 or
its mutation is associated with atopic
dermatitis (Chun et al., 2002; Li et al.,
2010), and keratinocyte-speciﬁc dele-
tion of murine caspase-8, or its essential
adaptor protein FADD, triggers chronic
inﬂammatory skin disease and the
upregulation of many genes induced
during epidermal wound healing
(Kovalenko et al., 2009; Lee et al.,
2009; Li et al., 2010; Bonnet et al.,
2011).
Epidermal capase-8 loss and NF-κB
signaling increase caspase-1 expression
The epidermis comprises mostly of
keratinocytes. Using epidermal explants
from mice lacking caspase-8 in kerati-
nocytes (Casp8ﬂ/ﬂ K14Cre), Jamora and
colleagues (Lee et al., 2015) show that
increased caspase-1 expression in
these mice is driven speciﬁcally by
NF-κB binding directly to the caspase-
1 promoter. In addition, elevated
caspase-1 was observed in epidermis
lacking the critical canonical NF-κB
inhibitor, IκBα. On the other hand,
increased NLRP3 levels found in
caspase-8-null epidermis were pre-
vented by inhibiting p38 mitogen-
activated protein kinase signaling but
not NF-κB. This regulation of caspase-1
and NLRP3 appears speciﬁc for kerati-
nocytes because previous research
using macrophages has shown no role
for TLR signals, which activate NF-κB,
in regulating caspase-1 expression,
whereas macrophage NLRP3, unlike
keratinocyte NLRP3, is induced in a
NF-κB-dependent manner (Bauernfeind
et al., 2009).
Interestingly, it was also observed
that increased epidermal caspase-1
mRNA levels in caspase-8-null cells
were suppressed by either neutralizing
caspase-1 activity, IL-1α, or co-deleting
the IL-1R. This implies that caspase-1-
mediated IL-1α secretion acts as part
of a feed-forward loop to induce NF-κB
and increase caspase-1 levels in either
an autocrine or a paracrine manner.
Collectively, these ﬁndings demonstrate
a unique mode for inﬂammasome prim-
ing in keratinocytes, one that may be
stimulated as part of the cutaneous
wound response. However, given that
keratinocytes express a number of differ-
ent inﬂammasomes that may recognize
bacteria (e.g., caspase-4 and -5), or
host DAMPs (e.g., AIM2), the analysis
of NLRP3-deﬁcient cells is required to
determine whether keratinocyte NLRP3
is responsible for IL-1α secretion follow-
ing excisional wounding or loss of
caspase-8. In addition, it remains unclear
what stimuli trigger inﬂammasome activ-
ity in wounded or caspase-8-depleted
skin, be it DAMPs released from dead
cells, inﬂammatory cytokines such as
TNF, or intrinsic activation of cellular
RIPK3 that is normally held in check by
caspase-8.
Caspase-1-induced secretion of IL-1α
propagates NF-κB activation and
inﬂammatory gene expression in vivo
Lee et al. (2015), next asked whether
their in vitro ﬁndings could also be
observed in vivo.
Notably, they found signiﬁcantly
increased caspase-1 levels in Casp8ﬂ/ﬂ
K14Cre epidermis that was reduced by
inhibiting NF-κB or caspase-1 itself, or
by co-deleting the IL-1R. Similarly,
diminished NF-κB activity in epidermal
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caspase-8 knockout mice, or mice with
excisional wounds, could be induced
by co-deletion of the IL-1R or caspase-
1. These data provide evidence to
suggest that epidermal caspase-1-
induced IL-1α secretion is likely to
amplify NF-κB-dependent caspase-1
expression in vivo. Notably, however,
caspase-1 inhibition did not blunt
caspase-1 expression in the very outer
epidermis, implying that inﬂammasome
activity in the upper epidermis drives
IL-1α secretion that acts in a paracrine
manner to activate NF-κB throughout
the tissue. These ﬁndings are in line
with those of Kovalenko et al. (2009),
who concluded that inﬂammatory
signals derive from the suprabasal
layer of caspase-8-deﬁcient epidermis.
Hence, Jamora and colleagues (Lee
et al., 2015) elegantly demonstrate,
both in vitro and in vivo, that caspase-
1-driven IL-1α secretion in the
outer epidermis is likely to amplify
NF-κB activation throughout the skin,
in either caspase-8 knockout epidermis
or as part of the cutaneous wound
response.
Caspase-1 and IL-1R deﬁciency delays
wound closure
Is the observed NF-κB, caspase-1, and
IL-1 axis reported by Jamora and collea-
gues (Lee et al., 2015) physiologically
relevant? Previous research has reported
that the chronic skin inﬂammation
resulting from keratinocyte FADD or
caspase-8 deletion is not altered by
co-deletion of the IL-1R (Kovalenko
et al., 2009; Bonnet et al., 2011).
However, permanent, widespread, and
complete caspase-8 loss in all keratino-
cytes will not necessarily reﬂect the
severity, timing, and spatial orientation
of caspase-8 downregulation observed
in cutaneous wounds. To address this
issue, the authors examined the con-
tribution of NF-κB, caspase-1, and IL-1
to wound healing using a punch biopsy
wound model. Notably, inhibition of
NF-κB, deletion of caspase-1, or loss of
the IL-1R delayed wound closure and
reduced immune cell inﬁltration into
the dermis. In fact, caspase-1 and IL-R
co-deletion in Casp8ﬂ/ﬂ K14Cre mice
mimicked these results. Moreover, there
was a marked reduction in inﬂamma-
tory gene expression in caspase-8-
deﬁcient skin when either caspase-1
was co-deleted or NF-κB inhibited, and
epidermal thickening, reﬂecting kerati-
nocyte proliferation, was not observed.
Collectively, these data suggest that
caspase-8 loss upon wounding and
subsequent inﬂammasome-associated
caspase-1 activation drives IL-1α and
IL-1β secretion. IL-1α, and possibly
IL-1β, promotes NF-κB activity through-
out the skin and drives inﬂammatory
cell inﬁltration, inﬂammatory gene
expression, and epithelial stem cell
proliferation. It is possible that IL-1 is
responsible, at least in part, for driving
IL-6 expression, as cutaneous wound
healing is also delayed in IL-6-deﬁcient
mice (Gallucci et al., 2000), and the
deletion of caspase-1 in caspase-8-
deﬁcient epidermis markedly reduced
the expression of many inﬂam-
matory mediators (Lee et al., 2015). It
is also important to consider that the
widespread NF-κB induction resulting
from caspase-1 and IL-1 activity may
induce inﬂammatory mediators that
both inhibit and promote wound heal-
ing, and, in this regard, it is interesting
to note that loss of the TNF receptor,
TNFR1, has the opposite effect to
IL-1R or IL-6 deletion and enhances
cutaneous wound closure (Mori et al.,
2002).
A role for RIPK3 and MLKL in the wound
response?
The chronic, amplifying, and eventually
overwhelming damage resulting from
permanent caspase-8 deletion in the
epidermis prevents the skin from healing,
or for the loss of the IL-1R to have any
long-lasting effect on disease progres-
sion. Nevertheless, recent studies have
shed some light into the key effectors of
the inﬂammatory response resulting from
epidermal caspase-8 loss. Caspase-8
critically represses RIPK3-induced
necroptosis and NLRP3 inﬂammasome
activation, and the loss of RIPK3 or MLKL
rescues the skin disease resulting from
FADD (Bonnet et al., 2011), RIPK1
(Rickard et al., 2014; Dillon et al.,
2014; Dannappel et al., 2014) or
caspase-8 deletion (Kaiser et al., 2011;
Oberst et al., 2011; Weinlich et al.,
2013). In contrast, deletion of the essen-
tial TLR adaptor, Myd88 (Kovalenko
et al., 2009; Bonnet et al., 2011), or the
RIG-I adaptor MAVs (Weinlich et al.,
2013), has only a minor or no effect
on disease progression in caspase-8 or
FADD deﬁcient epidermis. TNF/TNFR1
signaling can trigger RIPK3/MLKL-
induced necroptosis when caspase-8 is
repressed, and TNF or TNFR1 loss
markedly protected skin disease when
caspase-8 was acutely deleted in adult
mice, and signiﬁcantly delayed, but did
not prevent, disease in FADD and
caspase-8 keratinocyte-deﬁcient mice
(Kovalenko et al., 2009; Bonnet et al.,
2011). Necroptotic keratinocytes, as
observed upon epidermal FADD
deletion (Kovalenko et al., 2009), may
trigger a rapid inﬂammatory response
through the release of DAMPs, such as
IL-1α, IL-33, and HMGB1. Alternatively,
or at the same time, caspase-8 loss may
stabilize a RIPK1/RIPK3 complex to
induce TNF production and/or RIPK3/
MLKL-dependent NLRP3 inﬂammasome
activation before necroptotic cell death.
Regardless, one hypothesis consistent
with published data suggests that over-
whelming epidermal death, be it necrop-
tosis caused by keratinocyte caspase-8
deletion, or apoptosis resulting from
epidermal deletion of the caspase-8
inhibitor cFLIP (Panayotova-Dimitrova
et al., 2013; Weinlich et al., 2013),
results in irreversible skin damage.
Although inﬂammation induced by
DAMP release, and cytokines such as
TNF, may markedly accelerate this
process, ultimately the inﬂammatory
response may be inconsequential to the
ﬁnal outcome: epidermal demise and,
ultimately, animal death. In this regard,
macrophage or T-cell loss does not
impact the skin disease observed in
epidermal caspsae-8-deﬁcient mice
(Kovalenko et al., 2009), although the
importance of neutrophils or mast cells
has yet to be evaluated. This contrasts to
physical wounding, where macrophage
depletion signiﬁcantly delays healing
(Eming et al., 2007). The use of wound
models is therefore required to
dissect out what roles inﬂammasomes,
caspase-1, IL-1, RIPK3, and MLKL may
have in wound healing, where animals
are not subject to the overwhelming
trauma of complete epidermal caspase-
8 deletion.
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Some answers but more questions
Although the research reported in this
issue by Jamora and colleagues (Lee
et al., 2015) provides important inform-
ation into how caspase-1 and its activity
is regulated upon wounding or follow-
ing the depletion of keratinocyte cas-
pase-8, like most research, it raises even
more questions. For example, what is
the mechanism for caspase-8 down-
regulation in keratinocytes at the wound
edge? Does caspase-8 re-expression
during wound closure direct inﬂamma-
tory resolution? Does wound-induced
keratinocyte caspase-8 loss trigger
RIPK3 activation, and is RIPK3 respon-
sible for keratinocyte inﬂammasome
activity and/or TNF production? Is the
wound response, and cytokine produc-
tion, altered in RIPK3- or MLKL-
deﬁcient mice? Is the NLRP3 inﬂamma-
some responsible for epidermal IL-1α
and IL-1β secretion in wounded or
caspase-8-deﬁcient epidermis? Which
IL-1 member, IL-1α, IL-1β, or IL-18, is
required for optimal wound healing?
Answers to these questions may help
inform the search for new therapeutics
to treat inﬂammatory skin disorders and
promote beneﬁcial wound healing
responses.
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